Scientific Papers

Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma | Journal of Translational Medicine


  • Baumann F, Ambrosi JP, Carbone M. Asbestos is not just asbestos: an unrecognised health hazard. Lancet Oncol. 2013;14(7):576–8. https://doi.org/10.1016/S1470-2045(13)70257-2.

    Article 
    PubMed 

    Google Scholar
     

  • Sluis-Cremer GK, Liddell FD, Logan WP, Bezuidenhout BN. The mortality of amphibole miners in South Africa, 1946–80. Br J Ind Med. 1992;49(8):566–75. https://doi.org/10.1136/oem.49.8.566.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carbone M, Adusumilli PS, Alexander HR Jr, et al. Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69(5):402–29. https://doi.org/10.3322/caac.21572.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carbone M, Ly BH, Dodson RF, et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol. 2012;227(1):44–58. https://doi.org/10.1002/jcp.22724.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Alpert N, van Gerwen M, Taioli E. Epidemiology of mesothelioma in the 21(St) century in Europe and the United States, 40 years after restricted/banned asbestos use. Transl Lung Cancer Res. 2020;9(Suppl 1):28-S38. https://doi.org/10.21037/tlcr.2019.11.11.

    Article 

    Google Scholar
     

  • Baumann F, Carbone M. Environmental risk of mesothelioma in the United States: an emerging concern-epidemiological issues. J Toxicol Environ Health Part B Crit Rev. 2016;19(5–6):231–49. https://doi.org/10.1080/10937404.2016.1195322.

    Article 
    CAS 

    Google Scholar
     

  • Huang J, Chan SC, Pang WS, et al. Global incidence, risk factors, and temporal trends of mesothelioma: a population-based study. J Thorac Oncol. 2023;18(6):792–802. https://doi.org/10.1016/j.jtho.2023.01.095.

    Article 
    PubMed 

    Google Scholar
     

  • Walker-Bone K, Benke G, MacFarlane E, et al. Incidence and mortality from malignant mesothelioma 1982–2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry. Occup Environ Med. 2023;80(4):186–91. https://doi.org/10.1136/oemed-2022-108669.

    Article 
    PubMed 

    Google Scholar
     

  • Carbone M, Yang H, Pass H, Taioli E. Did the ban on asbestos reduce the incidence of mesothelioma? J Thorac Oncol. 2023;18(6):694–7.

    Article 
    PubMed 

    Google Scholar
     

  • Roggl VL, Green CL, Liu B, Carney JM, Glass CH, Pavlisko EN. Chronological trends in the causation of malignant mesothelioma: fiber burden analysis of 619 cases over four decades. Environ Res. 2023;230: 114530. https://doi.org/10.1016/j.envres.2022.114530.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Vimercati L, Cavone D, Delfino MC, et al. Asbestos air pollution: description of a mesothelioma cluster due to residential exposure from an asbestos cement factory. Int J Environ Res Public Health. 2020;17(8): 2636. https://doi.org/10.3390/ijerph17082636.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carbone M, Baris YI, Bertino P, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci USA. 2011;108(33):13618–23. https://doi.org/10.1073/pnas.1105887108.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Baumann F, Buck BJ, Metcalf RV, McLaurin BT, Merkler DJ, Carbone M. The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from southern Nevada. J Thorac Oncol. 2015;10(5):731–7. https://doi.org/10.1097/JTO.0000000000000506.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ryan PH, Dihle M, Griffin S, et al. Erionite in road gravel associated with interstitial and pleural changes—an occupational hazard in western United States. J Occup Environ Med. 2011;53(8):892–8. https://doi.org/10.1097/JOM.0b013e318223d44c.

    Article 
    PubMed 

    Google Scholar
     

  • Carbone M, Pass HI, Ak G, et al. Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations. J Thorac Oncol. 2022;17(7):873–89. https://doi.org/10.1016/j.jtho.2022.03.014.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hassan R, Morrow B, Walsh T, et al. Inherited predisposition to malignant mesothelioma (MM) due to mutations in DNA repair genes. J Clin Oncol. 2018;36(15suppl):8504–8504. https://doi.org/10.1200/JCO.2018.36.15_suppl.8504.

    Article 

    Google Scholar
     

  • Panou V, Gadiraju M, Wolin A, et al. Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol. 2018;36(28):2863–71. https://doi.org/10.1200/JCO.2018.78.5204.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bononi A, Goto K, Ak G, et al. Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma. Proc Natl Acad Sci USA. 2020;117(52):33466–73. https://doi.org/10.1073/pnas.2019652117.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pastorino S, Yoshikawa Y, Pass HI, et al. A subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations. J Clin Oncol. 2018;36(35):JCO2018790352. https://doi.org/10.1200/JCO.2018.79.0352.

    Article 
    PubMed 

    Google Scholar
     

  • Kadariya Y, Cheung M, Xu J, et al. Bap1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline Bap1 mutations. Cancer Res. 2016;76(9):2836–44. https://doi.org/10.1158/0008-5472.CAN-15-3371.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carbone M, Arron ST, Beutler B, et al. Tumour predisposition and cancer syndromes as models to study gene-environment interactions. Nat Rev Cancer. 2020;20(9):533–49. https://doi.org/10.1038/s41568-020-0265-y.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chirieac LR, Barletta JA, Yeap BY, et al. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol. 2013;31(36):4544–9. https://doi.org/10.1200/JCO.2013.49.9616.

    Article 
    PubMed 

    Google Scholar
     

  • Farioli A, Ottone M, Morganti AG, et al. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database. Cancer Med. 2016;5(5):950–9. https://doi.org/10.1002/cam4.656.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Baumann F, Flores E, Napolitano A, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36(1):76–81. https://doi.org/10.1093/carcin/bgu227.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mitchell OD, Gilliam K, Del Gaudio D, et al. Germline variants incidentally detected via tumor-only genomic profiling of patients with mesothelioma. JAMA Netw Open. 2023;6(8):e2327351. https://doi.org/10.1001/jamanetworkopen.2023.27351.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yano M, Ikeda Y, Kato T, et al. A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer. Mol Clin Oncol. 2018;8(2):302–5. https://doi.org/10.3892/mco.2017.1525.

    Article 
    PubMed 

    Google Scholar
     

  • Naeini YB, Arcega R, Hirschowitz S, Rao N, Xu H. Post-irradiation pericardial malignant mesothelioma with deletion of p16: a case report. Cancer Biol Med. 2018;15(1):97–102. https://doi.org/10.20892/j.issn.2095-3941.2017.0169.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guo Z, Carbone M, Zhang X, et al. Improving the accuracy of mesothelioma diagnosis in China. J Thorac Oncol. 2017;12(4):714–23. https://doi.org/10.1016/j.jtho.2016.12.006.

    Article 
    PubMed 

    Google Scholar
     

  • Chapel DB, Schulte JJ, Husain AN, Krausz T. Application of immunohistochemistry in diagnosis and management of malignant mesothelioma. Transl Lung Cancer Res. 2020;9(Suppl 1):3-S27. https://doi.org/10.21037/tlcr.2019.11.29.

    Article 
    CAS 

    Google Scholar
     

  • Bocchetta M, Di Resta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA. 2000;97(18):10214–9. https://doi.org/10.1073/pnas.170207097.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Qi F, Okimoto G, Jube S, et al. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-alpha signaling. Am J Pathol. 2013;183(5):1654–66. https://doi.org/10.1016/j.ajpath.2013.07.029.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yang H, Rivera Z, Jube S, et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA. 2010;107(28):12611–6. https://doi.org/10.1073/pnas.1006542107.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xue J, Patergnani S, Giorgi C, et al. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy. Proc Natl Acad Sci USA. 2020;117(41):25543–52. https://doi.org/10.1073/pnas.2007622117.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Novelli F, Bononi A, Wang Q, et al. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene x environment interaction with asbestos. Proc Natl Acad Sci USA. 2021. https://doi.org/10.1073/pnas.2111946118.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xue J, Suarez JS, Minaai M, et al. HMGB1 as a therapeutic target in disease. J Cell Physiol. 2021;236(5):3406–19. https://doi.org/10.1002/jcp.30125.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Larson D, Powers A, Ambrosi JP, et al. Investigating Palygorskite’s role in the development of mesothelioma in southern Nevada: insights into fiber-induced carcinogenicity. J Toxicol Environ Health Part B Crit Rev. 2016;19(5–6):213–30. https://doi.org/10.1080/10937404.2016.1195321.

    Article 
    CAS 

    Google Scholar
     

  • Comertpay S, Pastorino S, Tanji M, et al. Evaluation of clonal origin of malignant mesothelioma. J Transl Med. 2014;12:301. https://doi.org/10.1186/s12967-014-0301-3.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jube S, Rivera ZS, Bianchi ME, et al. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res. 2012;72(13):3290–301. https://doi.org/10.1158/0008-5472.CAN-11-3481.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yang H, Pellegrini L, Napolitano A, et al. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death Dis. 2015;6(6):e1786. https://doi.org/10.1038/cddis.2015.153.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pellegrini L, Xue J, Larson D, et al. HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Oncotarget. 2017;8(14):22649–61. https://doi.org/10.18632/oncotarget.15152.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mezzapelle R, De Marchis F, Passera C, et al. CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma. EMBO Mol Med. 2021;13(6): e12344. https://doi.org/10.15252/emmm.202012344.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Venturini M, Mezzapelle R, La Marca S, et al. Use of an antagonist of HMGB1 in mice affected by malignant mesothelioma: a preliminary ultrasound and optical imaging study. Eur Radiol Exp. 2022;6(1):7. https://doi.org/10.1186/s41747-021-00260-y.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Goparaju CM, Blasberg JD, Volinia S, et al. Onconase mediated NFKbeta downregulation in malignant pleural mesothelioma. Oncogene. 2011;30(24):2767–77. https://doi.org/10.1038/onc.2010.643.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nasu M, Carbone M, Gaudino G, et al. Ranpirnase interferes with NF-kappaB pathway and MMP9 activity, inhibiting malignant mesothelioma cell invasiveness and xenograft growth. Genes Cancer. 2011;2(5):576–84. https://doi.org/10.1177/1947601911412375.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kroczynska B, Cutrone R, Bocchetta M, et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci USA. 2006;103(38):14128–33. https://doi.org/10.1073/pnas.0604544103.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carbone M, Rizzo P, Pass H. Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res. 2000;20(2A):875–7.

    CAS 
    PubMed 

    Google Scholar
     

  • Carbone M, Gazdar A, Butel JS. SV40 and human mesothelioma. Transl Lung Cancer Res. 2020;9(Suppl 1):47-S59. https://doi.org/10.21037/tlcr.2020.02.03.

    Article 
    CAS 

    Google Scholar
     

  • Carbone M, Emri S, Dogan AU, et al. A Mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer. 2007;7(2):147–54. https://doi.org/10.1038/nrc2068.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Testa JR, Cheung M, Pei J, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43(10):1022–5. https://doi.org/10.1038/ng.912.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carbone M, Ferris LK, Baumann F, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl. 2012;10: 179. https://doi.org/10.1186/1479-5876-10-179.

    Article 
    CAS 

    Google Scholar
     

  • Lobb R. Michele Carbone: gene hunter of Hawai’i. American Association for Cancer Research. https://lnkd.in/d-dvZTde. Accessed 1 May 2023.

  • Carbone M, Harbour JW, Brugarolas J, et al. Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov. 2020;10(8):1103–20. https://doi.org/10.1158/2159-8290.CD-19-1220.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst. 2018;110(12):1328–41. https://doi.org/10.1093/jnci/djy171.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153–9. https://doi.org/10.1038/nrc3459.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bononi A, Giorgi C, Patergnani S, et al. BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature. 2017;546(7659):549–53. https://doi.org/10.1038/nature22798.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bononi A, Yang H, Giorgi C, et al. Germline BAP1 mutations induce a Warburg effect. Cell Death Differ. 2017;24(10):1694–704. https://doi.org/10.1038/cdd.2017.95.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang Y, Zhuang L, Gan B. BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression. Mol Cell Oncol. 2019;6(1): 1536845. https://doi.org/10.1080/23723556.2018.1536845.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Luo Y, Akatsuka S, Motooka Y, et al. BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile-induced mesothelioma via ferroptosis resistance. Cancer Sci. 2023;114(4):1423–36. https://doi.org/10.1111/cas.15705.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Louw A, Panou V, Szejniuk WM, et al. BAP1 loss by immunohistochemistry predicts improved survival to first-line platinum and pemetrexed chemotherapy for patients with pleural mesothelioma: a validation study. J Thorac Oncol. 2022;17(7):921–30. https://doi.org/10.1016/j.jtho.2022.04.008.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bononi A, Wang Q, Zolondick AA, et al. BAP1 is a novel regulator of HIF-1alpha. Proc Natl Acad Sci USA. 2023;120(4): e2217840120. https://doi.org/10.1073/pnas.2217840120.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nasu M, Emi M, Pastorino S, et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10(4):565–76. https://doi.org/10.1097/JTO.0000000000000471.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proc Natl Acad Sci USA. 2016;113(47):13432–7. https://doi.org/10.1073/pnas.1612074113.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guo G, Chmielecki J, Goparaju C, et al. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res. 2015;75(2):264–9. https://doi.org/10.1158/0008-5472.CAN-14-1008.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nabeshima K, Hamasaki M, Kinoshita Y, Matsumoto S, Sa-Ngiamwibool P. Update of pathological diagnosis of pleural mesothelioma using genomic-based morphological techniques, for both histological and cytological investigations. Pathol Int. 2022;72(8):389–401. https://doi.org/10.1111/pin.13235.

    Article 
    PubMed 

    Google Scholar
     



  • Source link